Injectables
Simtra BioPharma Solutions Announces Strategic Purchase to Expand U.S. Manufacturing Capacity for Injectable Medicines
Simtra BioPharma Solutions
PR-07-25-NI-3Jul 25, 2025
Expansion
Vetter Boosts Pharmaceutical Storage Capacity with Major Warehouse Expansion
Vetter Pharma International GmbH
PR-03-25-NI-04Mar 11, 2025
Capacity Expansion
CiVentiChem Increases Capacity by 300% with New Facility; Celebrates 30th Anniversary
CiVentiChem
PR-08-24-NI-02Aug 13, 2024
Expansion
Vetter looks ahead to further expansions to meet supply chain demand
Vetter Pharma International GmbH
PR-M10-23-03Oct 17, 2023
CDMO Service and Capacity Expansion
Pharma Service Provider Further Expands Offerings for Clinical Development and Manufacturing
Vetter Pharma International GmbH
PR-M05-23-01May 09, 2023
New Biomanufacturing Facility
Samsung Biologics Announces Construction of Plant 5 to Commence Bio Campus II Capacity Expansion
Samsung Biologics
PR-M03-23-05Mar 17, 2023
High Containment
Olon, Leading International API Supplier, Announces A New Investment That Will Further Expand its Global High Containment Platform a New High Containment Line in the Site Located in India
Olon
PR-M09-22-06Sep 27, 2022
Manufacturing Investment
MilliporeSigma Announces Investment of More Than € 130 Million to Strengthen Manufacturing Capabilities in Molsheim, France
MilliporeSigma
PR-M09-22-02Sep 08, 2022
Acquisition and Rebranding
Dr. Glenn Haifer and Ampersand Capital Partners Acquire Australian Biologics CDMO Luina Bio, Rebranding as AcuraBio
AcuraBio
PR-M09-22-01Sep 07, 2022
Site Expansion
Vetter’s Newest Clinical Manufacturing Site Successfully Completed Its First Customer Fills
Vetter Pharma International GmbH
PR-M06-22-07Jun 28, 2022
Capacity Expansion
Avid Bioservices Announces Further Expansion of Process Development Capacity for Mammalian Cell Business
Avid Bioservices
PR-M06-22-02Jun 13, 2022
New Facility
AGC Biologics Invests in Viral Vector Suspension at New U.S. Campus
AGC Biologics
PR-M05-22-13-359May 18, 2022
Financial Results
Samsung Biologics Reports First Quarter 2022 Financial Results
Samsung Biologics
PR-M04-22-14Apr 27, 2022
Vaccine and Cell & Gene Therapies
Expanding Manufacturing Capacity to Meet Market Demand for Vaccines and Cell and Gene Therapeutics
lrike Fiedler Dr. Rer. Nat.
IDT Biologika
PAO-04-022-CL-02Apr 13, 2022
Ambient Storage
Yourway Adds Additional Capacity for Controlled Ambient Storage in Allentown, PA
Yourway
PR-M04-22-07Apr 12, 2022
Facility Acquisition
Fujifilm Completes Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.
Fujifilm Biotechnologies
PR-M04-22-01Apr 04, 2022
Facility Expansion
Alcami Expands Biopharma Storage at Masy BioServices
Alcami
PR-M03-22-15Mar 29, 2022
Mergers and Acquisitions
Integrating Services Across the Full Spectrum of Cell and Gene Therapy
ProtaGene
PAO-02-22-R250-10Feb 11, 2022
Vaccines
IDT Biologika is Increasing its Production Capacity of Vaccines – Saxony-Anhalt's Prime Minister Reiner Haseloff Visited the New Facilities
IDT Biologika
PR-M01-22-13Jan 20, 2022
Expansion
FDA Accepts GMP Plasmid DMF and Capacity Expansion Enabling Andelyn Biosciences to Offer Faster Gene Therapy Development
Andelyn Biosciences
PR-M01-22-10Jan 13, 2022